Owner Isis Pharmaceuticals, Inc.

Inventors Allerson, Charles; Griffey, Richard H.; Prakash, Thazha P.; Dande, Prasad; Bhat, Balkrishen; Swayze, Eric E.

Agent Pizzeys

Pub. Number AU-B-2009222605

Parent 2004274021

Filing date 7 October 2009

Wipo publication date 12 November 2009

Acceptance publication date 9 December 2010

A01N 43/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/70 (2006.01) - Carbohydrates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07D 333/02 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/32 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/42 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07H 19/00 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay